DECAF Score for Acute Exacerbation of COPD
ورودیهای بالینی بیمار
حداقل ۳۵ — حداکثر ۱۲۰ • واحد: years
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–1
- Intermediate Risk2–2
- High Risk3–6
The DECAF Score for Acute Exacerbation of COPD calculator is designed for bedside predicting in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation in clinical practice. The resulting score directly guides clinician decision-making regarding determining appropriate admission.
Clinical Guidelines & Evidence
Predicts in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation.
Clinical Indication
The DECAF Score for Acute Exacerbation of COPD is indicated for bedside clinical practice to support Predicts in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management.
DECAF Score = Dyspnoea (0-2 points) + Eosinopenia (0-1 point) + Consolidation (0-1 point) + Acidaemia (0-1 point) + atrial Fibrillation (0-1 point)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| emrcd_dyspnea | string | Yes | Extended MRC Dyspnea Scale (eMRCD) - functional status assessment |
| eosinopenia | string | Yes | Eosinopenia (eosinophils <0.05×10⁹/L or <50 cells/μL) |
| consolidation | string | Yes | Consolidation on chest X-ray |
| acidemia | string | Yes | Acidemia (arterial blood gas pH <7.30) |
| atrial_fibrillation | string | Yes | Atrial fibrillation on ECG or history |
| patient_age | integer | No | Patient age in years (for clinical context, ≥35 years required for score validity)(years) |
| smoking_history | string | No | Smoking history for clinical context (≥10 pack-years required for score validity) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Low Risk | Low mortality risk |
| 2–2 | Intermediate Risk | Intermediate mortality risk |
| 3–6 | High Risk | High mortality risk |
Evidence-Based References (EBM)
- Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970-976. doi: 10.1136/thoraxjnl-2012-202103.DOI: 10.1136/thoraxjnl-2012-202103
- Echevarria C, Steer J, Heslop-Marshall K, et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133-140. doi: 10.1136/thoraxjnl-2015-207775.DOI: 10.1136/thoraxjnl-2015-207775
- Zhou M, Chen Y, Yang M, et al. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open. 2021;11(2):e044923. doi: 10.1136/bmjopen-2020-044923.DOI: 10.1136/bmjopen-2020-044923
- Nafae RM, Embarak S, Gad DM. Value of the DECAF score in predicting hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease admitted to Zagazig University Hospitals, Egypt. Egypt J Chest Dis Tuberc. 2015;64(1):35-40. doi: 10.1016/j.ejcdt.2014.07.006.DOI: 10.1016/j.ejcdt.2014.07.006